top of page
Lung Working Group Meetings occur on the Third Monday of the month from 12:00pm - 1:00pm

Lung Working Group

The Lung Working Group, led by physicians, Dr. Shruti Jolly (Michigan Medicine/MROQC Coordinating Center) and Dr. Peter Paximadis (Corewell Health South), and medical physicist, Dr. Martha Matuszak (Michigan Medicine/MROQC Coordinating Center), is currently working to identify ways to improve lung cancer treatment for patients across the state of Michigan.

Areas of Current and Ongoing Focus

  • Treatment technique and lung/esophagus toxicity evaluation (IMRT vs. 3DCRT)

  • Impact of pretreatment cardiac disease and radiation doses on long term heart complications

  • ​Understanding factors that contribute to poor patient outcomes post lung cancer treatment

  • ​Uptake and toxicity implications of Immunotherapy in definitive lung cancer treatment

  • Disparities in Lung Cancer Care

  • Improving Quality of Radiation Treatment Plan and Delivery  

  • Lung Target Delineation

  • Lung Target Coverage and Normal Tissue Dose Constraints

  • Lung Motion Assessment

  • Knowledge-Based Planning (KBP) to improve radiation plan quality

    Tools: MROQC Lung Pneumonitis Prediction App

MROQC lung working group

Support for MROQC is provided by Blue Cross Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program. Although Blue Cross Blue Shield of Michigan and MROQC work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.

BCBSM BCN_ProcessBlue_B.png

Blue Cross Blue Shield Michigan | Blue Care Network

Copyright - Michigan Radiation Oncology Quality Consortium (MROQC)

bottom of page